From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Keyword results: infection prevention products

Tristel – argues “stronger than ever” growth prospects, but what’s already in the price?

Infection prevention products manufacturer Tristel (TSTL) has announced results for its half-year ended 31st December 2022 emphasising “achieving 16% revenue growth and a 16-fold increase in EBITDA”. So what of the shares currently up to 330p, but still down from when I previously concluded bearishly a year ago?

Tristel – I having previously questioned how ‘confident for strong growth’, shares fall further on interims...

Previously writing on ‘infection prevention products’ company Tristel (TSTL), in October with the shares down to around 500p I concluded that still the valuation suggested entry into the US at a vast value indeed is needed and to avoid / sell. With the shares having last closed at 417.5p, what of today-announced half year results?…

Byotrol – interims, “pleased to announce”…“below management expectations”?!

Infection prevention and control products company Byotrol (BYOT) states that it “is pleased to announce” results for its half-year ended 30th September 2021. I previously concluded in April with the shares at 7p to avoid, they last closed at 5p…and are currently further lower at 4.275p. So what’s going on with trading?…

Tristel – full-year results, how ‘confident for strong growth’?...

Previously writing on ‘infection prevention products’ company Tristel (TSTL), in July with the shares at 620p I reviewed why they were down in response to ‘confident for strong growth’ update. Today full-year results, and the shares are further down.

Tristel – why are the shares down in response to ‘confident for strong growth’ update?...

‘Infection prevention products’ company Tristel (TSTL) has announced positive performance against expectations and confidence “for strong growth in the years ahead”. Why then are the shares, at 620p, currently more than 6% lower?…

PREMIUM CONTENT

Tristel – post-profit warning CEO shares purchase reassuring… or not?

“trading update” announcement from infection prevention and contamination control products company Tristel (TSTL) yesterday morning saw the shares down approaching 16% at 563p as I then wrote. What then of CEO Paul Swinney having since purchased shares at 572.75p each?

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Tristel – surface disinfectant product & international growth, BUT...

A trading update from infection prevention and contamination control products company Tristel (TSTL) includes “surface disinfectant product sales have continued to gain market share and UK sales for this product range to end of third quarter were £2.3m, 47% higher than in the same period last year” and “sales of our 13 overseas subsidiaries and to our international distributor network have increased by 7% over the comparable period last year”. So why are the shares, at 563p, currently approaching 16% down?…

Subscribe to ShareProphets to access Premium Content
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

Time left: 19:01:41